Abstract Combined asparaginase-based chemoradiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma (NKTCL), but haematologic toxicity and infection can compromise treatment delivery. We evaluated a chemotherapy-sparing induction regimen of camrelizumab, low-dose apatinib, and pegaspargase (CAPA) followed by sequential radiotherapy.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile